Alcohol abuse among adults with esophageal cancer and impact on outcomes of esophagectomy.

e16056 Background: Recent reports from the American Cancer Society confirmed a rising incidence, mortality rate, and burden of esophageal cancer in the United States. Although alcohol abuse is one of the key risk factors, its impact on the outcomes of esophageal cancer undergoing esophagectomy has not been well reported in the literature. Methods: This study relied on National Inpatient Sample records to evaluate patients with esophageal cancer admissions. We first estimated the prevalence of alcohol abuse among them(per 100,000 cases of esophageal cancer). Then, all patients undergoing esophagectomy were retained, and we explored the impact of alcohol abuse on their in-hospital outcomes. Results: Between 2016 and 2022, there were 283895 all-cause admissions involving esophageal cancer patients, with 19745(7.0%) having a history of alcohol abuse. The highest rate was noted in 2021(7.3%), with the lowest in 2016(6.5%). There were 21770 procedures of esophagectomy conducted during those calendar years, with 5.1%(1115) having a history of alcohol abuse. Those with alcohol abuse were younger (mean age of 61.37 vs. 64.31 years, p < 0.01), had a higher mean Charlson Comorbidity Index(CCI) score(4.02 vs. 3.65, p < 0.01), and contained more males (86.1% vs. 79.9%, p < 0.01), than the non-alcohol abuse group. Our cohort with alcohol abuse faced various in-hospital complications such as pneumonia (aOR 2.052, 95% CI 1.779-2.366, p < 0.01), postprocedural pneumothorax(aOR 1.776,95% CI1.370-2.302, p < 0.01), and sepsis(aOR 1.624, 95% CI 1.351-1.952, p < 0.01). Although bleeding events between the two groups were not different(aOR 1.516, 95% CI 0.938-2.449, p = 0.09), the need for blood transfusion was higher among the alcohol abuse patients (aOR 1.944, 95% CI 1.604-2.356, p < 0.01). Alcohol abuse also involved a heavier burden on healthcare, as the patients stayed on average for 16.66 days (vs. 13.45 days, p < 0.01) and also had higher odds of all-cause death (aOR 1.864, 95% CI 1.449-2.397, p < 0.01). Conclusions: Our findings confirm that esophageal cancer patients with alcohol abuse who were undergoing esophagectomy were younger, with a higher mortality burden, and experienced more complications. Such results underscore the need to address alcohol consumption as a modifiable risk factor and to evaluate adequate preoperative screening and targeted measures that can help improve surgical outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e16056
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alcohol abuse among adults with esophageal cancer and impact on outcomes of esophagectomy.

Archit Gupta, Dhruvkumar Gadhiya, Suma Sri Chennapragada, Hemamalini Sakthivel et al.
Journal of Clinical Oncology
Esophageal Cancer Research and Treatment
article

Alcohol abuse among adults with esophageal cancer and impact on outcomes of esophagectomy.

Archit Gupta, Dhruvkumar Gadhiya, Suma Sri Chennapragada, Hemamalini Sakthivel, Anthony Tannous, Kamleshun Ramphul, Saisree Reddy Adla Jala, Renuka Verma, Anaiya Singh, Yara Alnaber
article en

Abstract

e16056 Background: Recent reports from the American Cancer Society confirmed a rising incidence, mortality rate, and burden of esophageal cancer in the United States. Although alcohol abuse is one of the key risk factors, its impact on the outcomes of esophageal cancer undergoing esophagectomy has not been well reported in the literature. Methods: This study relied on National Inpatient Sample records to evaluate patients with esophageal cancer admissions. We first estimated the prevalence of alcohol abuse among them(per 100,000 cases of esophageal cancer). Then, all patients undergoing esophagectomy were retained, and we explored the impact of alcohol abuse on their in-hospital outcomes. Results: Between 2016 and 2022, there were 283895 all-cause admissions involving esophageal cancer patients, with 19745(7.0%) having a history of alcohol abuse. The highest rate was noted in 2021(7.3%), with the lowest in 2016(6.5%). There were 21770 procedures of esophagectomy conducted during those calendar years, with 5.1%(1115) having a history of alcohol abuse. Those with alcohol abuse were younger (mean age of 61.37 vs. 64.31 years, p < 0.01), had a higher mean Charlson Comorbidity Index(CCI) score(4.02 vs. 3.65, p < 0.01), and contained more males (86.1% vs. 79.9%, p < 0.01), than the non-alcohol abuse group. Our cohort with alcohol abuse faced various in-hospital complications such as pneumonia (aOR 2.052, 95% CI 1.779-2.366, p < 0.01), postprocedural pneumothorax(aOR 1.776,95% CI1.370-2.302, p < 0.01), and sepsis(aOR 1.624, 95% CI 1.351-1.952, p < 0.01). Although bleeding events between the two groups were not different(aOR 1.516, 95% CI 0.938-2.449, p = 0.09), the need for blood transfusion was higher among the alcohol abuse patients (aOR 1.944, 95% CI 1.604-2.356, p < 0.01). Alcohol abuse also involved a heavier burden on healthcare, as the patients stayed on average for 16.66 days (vs. 13.45 days, p < 0.01) and also had higher odds of all-cause death (aOR 1.864, 95% CI 1.449-2.397, p < 0.01). Conclusions: Our findings confirm that esophageal cancer patients with alcohol abuse who were undergoing esophagectomy were younger, with a higher mortality burden, and experienced more complications. Such results underscore the need to address alcohol consumption as a modifiable risk factor and to evaluate adequate preoperative screening and targeted measures that can help improve surgical outcomes.

Journal of Clinical OncologyVol. 43(16_suppl)
University of Jordan (JO), St. Luke's University Health Network (US), University of Nevada, Las Vegas (US), Al-Balqa Applied University (JO), CHRISTUS St. Michael Health System (US), Mahatma Gandhi Mission Medical College and Hospital (IN), Mission Hospital (US), Louisiana State University Health Sciences Center Shreveport (US)
Openalex Percentile: Top 79%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.